Saturday, January 17, 2026

Latest

Maxar Technologies Sees Canaccord Lift Price Target To US$40

On May 25, the U.S National Reconnaissance Office (NRO) announced that they awarded Maxar Technologies (TSX: MAXR) an Electro-Optical Commercial Layer (EOCL) contract. The contract is for a base 5 years with the option to extend the contract for an additional 5 years. The deal is said to represent the largest ever commercial imagery acquisition contract awarded by the NRO.

In a separate news release, Maxar updated its full-year 2022 guidance by $30 million. They now expect full-year revenues to come in between $1.805 billion to $1.855 billion, while adjusted EBITDA guidance is now between $455 million and $505 million.

Maxar currently has 7 analysts covering the stock with an average 12-month price target of US$44.14, or an upside of 48%. Out of the 7 analysts, 1 has a strong buy rating, 3 have buy ratings and the last 3 analysts have hold ratings. The street high price target sits at US$52 from 2 analysts, which is an upside of 75%.

In Canaccord Genuity’s note on the news, they reiterate their buy rating and raise their 12-month price target from US$38 to US$40, saying that the ECOL contract to Maxar “was particularly favorable given the addition of new vendors to the sole source program status.”

They note that the contract is worth roughly $300 million per year for the first 5 years with options to extend and increase the costs to $340 million per year. Though the NRO has the potential to go above the base contract as the contract allows the NRO the flexibility to increase their utilization of Maxar’s Legion satellites.

During the subsequent call, Canaccord asked Maxar’s management if this could represent “tens of millions of incremental revenue.” Management confirmed this and said it was “in the realm of possibility” for the first few years.

Canaccord says that the contract wins on EnhancedView, “not only demonstrates the company’s ironclad relationship with DoD but shows the underlying TAM pie for EO imagery collection is growing significantly.” They believe that Maxar’s satellites have a “hefty technical edge” over its peers when you compare contract sizes to other award winners.

Lastly, on the price target increase, Canaccord says that, “While investors are currently fighting headwinds from the market, given difficult
economic conditions, inflation, and rising interest rates,” they continue to believe that Maxar’s stock is currently undervalued due to its competitive moat and solid relationship with different arms of the government.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Recommended

NexGen Launches 42,000 Metre Drill Program At PCE While Expanding Mineralized Footprint

First Majestic Hits 2025 Guidance, Producing 31.1 Million Silver Equivalent Ounces, Increases Dividend

Related News

Cresco Labs: Haywood Marginally Revises Estimates Following Cultivate Acquisition

On September 3, Cresco Labs (CSE: CL) announced that they have closed their acquisition of...

Friday, September 10, 2021, 10:56:00 AM

Mind Medicine: Canaccord Maintains Ratings Following Financial Results

On Friday, November 13th, Mind Medicine (NEO: MMED) reported their third quarter 2020 financial results....

Tuesday, November 17, 2020, 10:17:00 AM

Cineplex: Canaccord Pegs Chance Of $1.24 Billion In Damages Being Collected At 25%

On December 15th, Cineplex Inc. (TSX: CGX) was awarded roughly $1.24 billion in damages from...

Sunday, December 19, 2021, 03:17:00 PM

Cresco Labs: Analysts Raise Targets Following Blowout Quarter

On November 18th, Cresco Labs (CSE: CL) reported their third quarter financial results. The company...

Friday, November 20, 2020, 12:09:00 PM

Organigram: Consensus Analyst Estimates For Q2 2021

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April...

Saturday, April 10, 2021, 01:35:00 PM